TRILINK BIOTECHNOLOGIES LLC
TRILINK BIOTECHNOLOGIES LLC, headquartered in the United States, is a leading player in the biotechnology industry, specialising in nucleic acid synthesis and related services. Founded in 2000, the company has established itself as a trusted partner for researchers and organisations across the globe, with a strong operational presence in North America and Europe. TRILINK offers a diverse range of core products, including custom oligonucleotides, RNA synthesis, and modified nucleotides, all designed to meet the evolving needs of the scientific community. Their commitment to quality and innovation sets them apart, ensuring that clients receive superior products tailored to their specific applications. With a reputation for excellence, TRILINK has achieved significant milestones, solidifying its position as a preferred supplier in the biotechnology sector.
DitchCarbon Score
How does TRILINK BIOTECHNOLOGIES LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TRILINK BIOTECHNOLOGIES LLC's score of 13 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TRILINK BIOTECHNOLOGIES LLC's reported carbon emissions
TRILINK BIOTECHNOLOGIES LLC, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may suggest that TRILINK BIOTECHNOLOGIES LLC is still in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, it will be essential for TRILINK BIOTECHNOLOGIES LLC to establish clear climate commitments and reduction initiatives to align with global climate goals and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TRILINK BIOTECHNOLOGIES LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
